Hepatitis B cure: treatment priorities and cost-effectiveness study
Part of Digestive system, Infections clinical trials.
This study looks at how doctors decide which patients to prioritize for hepatitis B cure, and how cost-effective these treatments are. If you have been cured of hepatitis B, your information can help improve care for others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with chronic hepatitis B (a long-term liver infection caused by the hepatitis B virus).
- Your doctor has confirmed that your hepatitis B is cured, which means your hepatitis B surface antigen (a protein in the blood) has become negative (undetectable).
- You are 18 years old or older.
- You do not have a serious illness or cancer that limits your life expectancy to less than 1 year.
- Your age and gender are known and recorded.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how different outcomes of chronic hepatitis B treatment affect patients' quality of life. It includes people who have been functionally cured, those still on treatment, those who relapsed, and healthy controls to compare.
This study looks at genetic factors that may help people with chronic hepatitis B achieve a clinical cure when treated with long-acting interferon. It aims to find out why some patients respond better than others.
This study tests whether a combination of two drugs (ASC22 and Peg-IFN) can help people with chronic hepatitis B achieve a functional cure. The goal is to see if this therapy can clear the virus and improve liver health.
This study looks at how patients with chronic hepatitis B are managed when they visit non-liver clinics. It aims to improve care and may also include a survey about quality of life for those starting treatment.
This study looks at whether extra treatment with peginterferon (a drug that boosts the immune system) can help lower the amount of hidden hepatitis B virus in the liver after you've already reached clinical cure. You'll have two liver biopsies to measure this, and the findings may help prevent the virus from coming back.
This trial is for people with chronic hepatitis B who have already cleared the virus with interferon treatment. It tests ongoing strategies to help maintain their health and prevent the virus from coming back.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.